Sign In
Buy EVFM
$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026
Fulcrum Therapeutics, Evofem Biosciences Drug Candidates Receive FDA Fast Track Designation
04:19pm, Wednesday, 12'th May 2021
The FDA has granted Fast Track designation to Fulcrum Therapeutics Inc's (NASDAQ: FULC) losmapimod for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum is on trac
Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May
12:21pm, Wednesday, 12'th May 2021
Biotech penny stocks are heating up right now; here's 4 to watch The post Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May appeared first on Penny Stocks to Buy, Picks, News and Inform
5 Hot Penny Stocks To Buy? Check These Out For May 2021
04:27pm, Monday, 10'th May 2021
Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?
Evofem: Phexxi Scripts Tracking Ahead Of Model, But Market Is Unimpressed
05:58am, Monday, 10'th May 2021
Phexxi new prescriptions are being generated at a higher rate than I modeled in my valuation estimates.
EVFM Stock: Over 5% Increase Pre-Market Explanation
07:46am, Friday, 07'th May 2021
The stock price of Evofem Biosciences Inc (NASDAQ: EVFM) increased by over 5% pre-market. This is why it happened.
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2021 Results - Earnings Call Transcript
10:34pm, Thursday, 06'th May 2021
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2021 Results - Earnings Call Transcript
SAN DIEGO, April 28, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi® (lactic acid, citric acid,
Evofem Biosciences to Report First Quarter 2021 Results and Provide Corporate Update on Thursday, May 6, 2021
08:00am, Thursday, 22'nd Apr 2021
SAN DIEGO, April 22, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for the
Evofem Biosciences to Deliver Keynote Address and Present Two Phexxi Data Sets at NCODA 2021 National Spring Forum
08:00am, Wednesday, 21'st Apr 2021
SAN DIEGO, April 21, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced the company will deliver the keynote address and present two poster presentations on Phexxi® (lacti
Evofem Biosciences Announces Closing of Public Offering of Common Stock
04:05pm, Monday, 29'th Mar 2021
SAN DIEGO, March 29, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 17,142,857 shares of its commo
Why Cellect, Immutep, F-star, ProQR and Evofem Are Moving Thursday
12:22pm, Thursday, 25'th Mar 2021
Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.
Evofem Biosciences Announces Pricing of $30 Million Public Offering of Common Stock
10:00pm, Wednesday, 24'th Mar 2021
SAN DIEGO, March 24, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a price t
Evofem Biosciences Announces Proposed Public Offering of Common Stock
04:00pm, Wednesday, 24'th Mar 2021
SAN DIEGO, March 24, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to offer and sell, subject to market and other conditions, $30 million of shares of i
Evofem Biosciences' DTC Campaign "Get Phexxi" Delivers Strong Initial Impact
08:00am, Wednesday, 17'th Mar 2021
SAN DIEGO, March 17, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that "Get Phexxi," its national direct-to-consumer (DTC) campaign aimed at broadening awareness of
7 Stocks for Sale That Have Insider Buying
11:51am, Tuesday, 16'th Mar 2021
Insiders sell for many reasons, but they only buy for one. To make money.
